EXPERIMENTAL STUDY
Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy
Junya Shite, MD*,
Fuzhong Qin, MD, PhD*,
Weike Mao, MD*,
Hiroya Kawai, MD*,
Suzanne Y. Stevens, PhD and
Chang-seng Liang, MD, PhD, FACC*,*
* Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
Department of Neurobiology and Anatomy, University of Rochester Medical Center, Rochester, New York, USA
Manuscript received March 30, 2001;
revised manuscript received July 17, 2001,
accepted August 13, 2001.
* Reprint requests and correspondence: Dr. Chang-seng Liang, University of Rochester Medical Center, Cardiology Unit, Box 679, 601 Elmwood Avenue, Rochester, New York 14642 USA
chang-seng_liang{at}urmc.rochester.edu
OBJECTIVES
We administered antioxidant vitamins to rabbits with pacing-induced cardiomyopathy to assess whether antioxidant therapy retards the progression of congestive heart failure (CHF).
BACKGROUND
Although oxidative stress is increased in CHF, whether progression of heart failure could be prevented or reduced by antioxidants is not known.
METHODS
Rabbits with chronic cardiac pacing and sham operation were randomized to receive a combination of beta-carotene, ascorbic acid and alpha-tocopherol, alpha-tocopherol alone or placebo over eight weeks. Echocardiography was used to measure cardiac function weekly. Resting hemodynamics and in vivo myocardial beta-adrenergic responsiveness were studied at week 8. Animals were then sacrificed for measuring myocardial beta-receptor density, norepinephrine (NE) uptake-1 site density, sympathetic neuronal marker profiles, tissue-reduced glutathione/oxidized glutathione (GSH/GSSG) ratio and oxidative damage of mitochondrial DNA (mtDNA).
RESULTS
Rapid cardiac pacing increased myocardial oxidative stress as evidenced by reduced myocardial GSH/GSSG ratio and increased oxidized mtDNA and produced cardiac dysfunction, beta-adrenergic subsensitivity, beta-receptor downregulation, diminished sympathetic neurotransmitter profiles and reduced NE uptake-1 carrier density. A combination of antioxidant vitamins reduced the myocardial oxidative stress, attenuated cardiac dysfunction and prevented myocardial beta-receptor downregulation and sympathetic nerve terminal dysfunction. Administration of alpha-tocopherol alone produced similar effects, but the effects were less marked than those produced by the three vitamins together. Vitamins produced no effects in sham-operated animals.
CONCLUSIONS
Antioxidant vitamins reduced tissue oxidative stress in CHF and attenuated the associated cardiac dysfunction, beta-receptor downregulation and sympathetic nerve terminal abnormalities. The findings suggest that antioxidant therapy may be efficacious in human CHF.
|
Abbreviations and Acronyms
| | CHF | = congestive heart failure | | dP/dt | = first derivative of LV pressure | | dG | = 2'-deoxyguanosine | | EDD | = end-diastolic dimension | | ESD | = end-systolic dimension | | FS | = fractional shortening | | GSH | = reduced glutathione | | GSSG | = oxidized glutathione | | LV | = left ventricular | | MI | = myocardial infarction | | mtDNA | = mitochondrial DNA | | NE | = norepinephrine | | 8-oxo-dG | = 8-oxo-7,8-dihydro-2'-deoxyguanosine |
|
This article has been cited by other articles:
|
|
|
|
 
R. Sethi, A. Adameova, K. S. Dhalla, M. Khan, V. Elimban, and N. S. Dhalla
Modification of Epinephrine-induced Arrhythmias by N-Acetyl-L-Cysteine and Vitamin E
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2009;
14(2):
134 - 142.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Rohrbach, A. Martin, B. Niemann, and A. Cherubini
Enhanced myocardial vitamin C accumulation in left ventricular hypertrophy in rats is not attenuated with transition to heart failure
Eur J Heart Fail,
March 1, 2008;
10(3):
226 - 232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Kokusho, T. Komaru, S. Takeda, K. Takahashi, R. Koshida, K. Shirato, and H. Shimokawa
Hydrogen Peroxide Derived From Beating Heart Mediates Coronary Microvascular Dilation During Tachycardia
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
1057 - 1063.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Otake, J. Shite, O. L. Paredes, T. Shinke, R. Yoshikawa, Y. Tanino, S. Watanabe, T. Ozawa, D. Matsumoto, D. Ogasawara, et al.
Catheter-Based Transcoronary Myocardial Hypothermia Attenuates Arrhythmia and Myocardial Necrosis in Pigs With Acute Myocardial Infarction
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
250 - 260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Shanmugam, T.P. Chua, and D. Ward
'Frequent' ventricular bigeminy - A reversible cause of dilated cardiomyopathy. How frequent is 'frequent'?
Eur J Heart Fail,
December 1, 2006;
8(8):
869 - 873.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-s. Liang, W. Mao, C. Iwai, S. Fukuoka, and S. Y. Stevens
Cardiac sympathetic neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy
Am J Physiol Heart Circ Physiol,
March 1, 2006;
290(3):
H995 - H1003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. De Young, D. Yu, R. M. Bateman, and G. B. Brock
Oxidative Stress and Antioxidant Therapy: Their Impact in Diabetes-Associated Erectile Dysfunction
J Androl,
September 1, 2004;
25(5):
830 - 836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C.-s. Liang
Importance of antioxidant and antiapoptotic effects of {beta}-receptor blockers in heart failure therapy
Am J Physiol Heart Circ Physiol,
September 1, 2004;
287(3):
H1003 - H1012.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Mao, F. Qin, C. Iwai, R. Vulapalli, P. C. Keng, and C.-s. Liang
Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells
Am J Physiol Heart Circ Physiol,
July 1, 2004;
287(1):
H29 - H39.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Moritz, C. Monteil, M. Isabelle, F. Bauer, S. Renet, P. Mulder, V. Richard, and C. Thuillez
Role of reactive oxygen species in cocaine-induced cardiac dysfunction
Cardiovasc Res,
October 1, 2003;
59(4):
834 - 843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Qin, J. Shite, and C.-s. Liang
Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways
Am J Physiol Heart Circ Physiol,
July 11, 2003;
285(2):
H822 - H832.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-s. Liang, A. Yatani, Y. Himura, M. Kashiki, and S. Y. Stevens
Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion
Am J Physiol Heart Circ Physiol,
May 1, 2003;
284(5):
H1729 - H1736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-S. Liang, Y. Himura, M. Kashiki, and S. Y. Stevens
Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF
Am J Physiol Heart Circ Physiol,
November 1, 2002;
283(5):
H1863 - H1872.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
